The Oncosearch | Oncotarget

Advancements in bladder cancer treatment: The synergy of radiation and immunotherapy Review

Nazmul Hasan, Daniel Yang, Spencer Gibson, Barbod Khaleghi, Rozhan Ziari, Arash Rezazadeh Kalebasty

Published May 8, 2025 · Vol. 16, No. 1 · pp. 337-346

Keywords: bladder cancer, immunotherapy, radiation, microenvironment, abscopal

Computed tomography-based radiomics and body composition model for predicting hepatic decompensation Research Paper

Yashbir Singh, John E. Eaton, Sudhakar K. Venkatesh, Bradley J. Erickson

Published Nov 11, 2024 · Vol. 15, No. 1 · pp. 809-813

Keywords: radiomics, body composition, machine learning, primary sclerosing cholangitis, computer tomography

HER2-low and HER2-zero in breast cancer between prognosis, prediction and entity Editorial

Marcus Schmidt, Hans-Anton Lehr, Katrin Almstedt

Published Jun 15, 2024 · Vol. 15, No. 1 · pp. 418-420

Keywords: breast cancer, HER2, HER2-low, prognostic, predictive

Bruton’s tyrosine kinase inhibitor-related cardiotoxicity: The quest for predictive biomarkers and improved risk stratification Research Perspective

Jai N. Patel, Jai Singh, Nilanjan Ghosh

Published May 25, 2024 · Vol. 15, No. 1 · pp. 355-359

Keywords: BTK inhibitor, cardiotoxicity, biomarkers, risk, genetics

GZ17-6.02 kills PDX isolates of uveal melanoma Research Paper

Laurence Booth, Jane L. Roberts, Ivan Spasojevic, Kaitlyn C. Baker, Andrew Poklepovic, Cameron West, John M. Kirkwood, Paul Dent

Published May 9, 2024 · Vol. 15, No. 1 · pp. 328-344

Keywords: autophagy, ER stress, GZ17-6.02, doxorubicin, afatinib, neratinib

Combining causal and correlative approaches to discover biomarkers of response to paclitaxel Research Perspective

Alberto Moscona-Nissan, Karl J. Habashy, Victor A. Arrieta, Adam M. Sonabend, Crismita Dmello

Published Jan 2, 2024 · Vol. 15, No. 1 · pp. 117-122

Keywords: glioblastoma, predictive biomarker, CRISPR screen, paclitaxel

Peripheral surrogates of tumor burden to guide chemotherapeutic and immunotherapeutic strategies for HPV-associated malignancies Review

Meghali Goswami, Jeffrey Schlom, Renee N. Donahue

Published Aug 3, 2023 · Vol. 14, No. 1 · pp. 758-774

Keywords: HPV-associated malignancies, immunotherapy, circulating tumor DNA, circulating tumor cells, HPV-specific antibodies

HER3- A key survival pathway and an emerging therapeutic target in metastatic colorectal cancer and pancreatic ductal adenocarcinoma Research Perspective

Omkar Desai, Rui Wang

Published Apr 28, 2023 · Vol. 14, No. 1 · pp. 439-443

Keywords: HER3, colorectal, pancreatic cancer, metastasis, microenvironment

Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer Research Paper

Noriyuki Hirahara, Takeshi Matsubara, Shunsuke Kaji, Hikota Hayashi, Yohei Sasaki, Koki Kawakami, Ryoji Hyakudomi, Tetsu Yamamoto, Yoshitsugu Tajima

Published Jan 25, 2023 · Vol. 14, No. 1 · pp. 71-82

Keywords: gastric cancer, laparoscopic gastrectomy, novel predictive index, inflammation-combined prognostic index, cancer-specific survival

Mutation analysis performed on tumor biopsies from patients with newly-diagnosed germinal center aggressive B cell lymphomas Research Paper

Daniel J. Landsburg, Jennifer J.D. Morrissette, Stephen J. Schuster, Sunita D. Nasta, James N. Gerson, Stefan K. Barta, Jakub Svoboda, Elise A. Chong, Megan S. Lim

Published Nov 5, 2022 · Vol. 13, No. 1 · pp. 1237-1244

Keywords: diffuse large B cell lymphoma, high grade B cell lymphoma, mutation analysis, next generation sequencing, chemotherapy

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study Research Paper

Jun Gong, Michelle Guan, Haesoo Kim, Natalie Moshayedi, Sejal Mehta, Galen Cook-Wiens, Brent K. Larson, Jenny Zhou, Rishi Patel, Isaac Lapite, Veronica R. Placencio-Hickok, Richard Tuli, Ronald B. Natale, Andrew E. Hendifar

Published Oct 25, 2022 · Vol. 13, No. 1 · pp. 1202-1214

Keywords: hyaluronan, hyaluronic acid, biomarker, prognostic, predictive

Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer Research Paper

Neal Murphy, Andrew J. Shih, Paras Shah, Oksana Yaskiv, Houman Khalili, Anthony Liew, Annette T. Lee, Xin-Hua Zhu

Published Oct 20, 2022 · Vol. 13, No. 1 · pp. 1188-1200

Keywords: muscle invasive bladder cancer, neoadjuvant chemotherapy, gene expression, molecular subtyping, canonical correlation analysis

Effectiveness of radiotherapy for local control in T3N0 rectal cancer managed with total mesorectal excision: a meta-analysis Research Paper

Michael Jonathan Kucharczyk, Andrew Bang, Michael C. Tjong, Stefania Papatheodorou, Jesus C. Fabregas

Published Sep 30, 2022 · Vol. 13, No. 1 · pp. 1109-1119

Keywords: radiotherapy, meta-analysis, systematic review, rectal cancer, total mesorectal excision

Genomic alterations predictive of poor clinical outcomes in pan-cancer Research Paper

Crystal S. Seldon, Karthik Meiyappan, Hannah Hoffman, Jimmy A. Guo, Neha Goel, William L. Hwang, Paul L. Nguyen, Brandon A. Mahal, Mohammed Alshalalfa

Published Sep 20, 2022 · Vol. 13, No. 1 · pp. 1069-1077

Keywords: genomic alterations, TP53, TCGA, poor prognosis

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma Research Paper

Francis R. LeBlanc, Zainul S. Hasanali, August Stuart, Sara Shimko, Kamal Sharma, Violetta V. Leshchenko, Samir Parekh, Haiqing Fu, Ya Zhang, Melvenia M. Martin, Mark Kester, Todd Fox, Jiangang Liao, Thomas P. Loughran, Juanita Evans, Jeffrey J. Pu, Stephen E. Spurgeon, Mirit I. Aladjem, Elliot M. Epner

Published Jul 9, 2022 · Vol. 13, No. 1 · pp. 986-1002

Keywords: epigenetics, blastic mantle cell lymphoma, cladribine

Predicting cancer immunotherapy response from gut microbiomes using machine learning models Research Paper

Hai Liang, Jay-Hyun Jo, Zhiwei Zhang, Margaret A. MacGibeny, Jungmin Han, Diana M. Proctor, Monica E. Taylor, You Che, Paul Juneau, Andrea B. Apolo, John A. McCulloch, Diwakar Davar, Hassane M. Zarour, Amiran K. Dzutsev, Isaac Brownell, Giorgio Trinchieri, James L. Gulley, Heidi H. Kong

Published Jun 28, 2022 · Vol. 13, No. 1 · pp. 876-889

Keywords: gut microbiome, immunotherapy, 16S rRNA, machine learning, metagenomics

Are anaplastic lymphoma kinase (ALK) and O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation driver biomarkers of pulmonary neuroendocrine tumors (NETs) and carcinomas (NECs)? Research Paper

Birgitta Hiddinga, Karen Zwaenepoel, Annelies Janssens, Jan Van Meerbeeck, Patrick Pauwels

Published May 13, 2022 · Vol. 13, No. 1 · pp. 800-809

Keywords: MGMT promoter methylation, anaplastic lymphoma kinase, neuroendocrine tumor, neuroendocrine carcinoma, small cell lung cancer

Deciphering miR-520c-3p as a probable target for immunometabolism in non-small cell lung cancer using systems biology approach Research Paper

Pooja Gulhane, Prajakta Nimsarkar, Komal Kharat, Shailza Singh

Published May 7, 2022 · Vol. 13, No. 1 · pp. 725-746

Keywords: non-small cell lung cancer, miRNAs, miR-520c-3p, PI3K/AKT signaling pathway, therapeutic targeting

Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptations Review

Antonio Marchetti, Fiamma Buttitta, Emanuela D’Angelo

Published Feb 25, 2022 · Vol. 13, No. 1 · pp. 456-463

Keywords: non-small cell lung cancer, osimertinib, diagnostics, early, survival

Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers Research Paper

Ami N. Shah, Ashwin Sunderraj, Brian Finkelman, Sharlene H. See, Andrew A. Davis, Lorenzo Gerratana, Firas Wehbe, Neelima Katam, Deva Mahalingam, William J. Gradishar, Amir Behdad, Luis Blanco, Massimo Cristofanilli

Published Jan 26, 2022 · Vol. 13, No. 1 · pp. 273-280

Keywords: ERBB2, HER2, next-generation sequencing, copy number gain, circulating tumor DNA

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Advancements in bladder cancer treatment: The synergy of radiation and immunotherapy Review

Computed tomography-based radiomics and body composition model for predicting hepatic decompensation Research Paper

HER2-low and HER2-zero in breast cancer between prognosis, prediction and entity Editorial

Bruton’s tyrosine kinase inhibitor-related cardiotoxicity: The quest for predictive biomarkers and improved risk stratification Research Perspective

GZ17-6.02 kills PDX isolates of uveal melanoma Research Paper

Combining causal and correlative approaches to discover biomarkers of response to paclitaxel Research Perspective

Peripheral surrogates of tumor burden to guide chemotherapeutic and immunotherapeutic strategies for HPV-associated malignancies Review

HER3- A key survival pathway and an emerging therapeutic target in metastatic colorectal cancer and pancreatic ductal adenocarcinoma Research Perspective

Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer Research Paper

Mutation analysis performed on tumor biopsies from patients with newly-diagnosed germinal center aggressive B cell lymphomas Research Paper

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study Research Paper

Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer Research Paper

Effectiveness of radiotherapy for local control in T3N0 rectal cancer managed with total mesorectal excision: a meta-analysis Research Paper

Genomic alterations predictive of poor clinical outcomes in pan-cancer Research Paper

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma Research Paper

Predicting cancer immunotherapy response from gut microbiomes using machine learning models Research Paper

Are anaplastic lymphoma kinase (ALK) and O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation driver biomarkers of pulmonary neuroendocrine tumors (NETs) and carcinomas (NECs)? Research Paper

Deciphering miR-520c-3p as a probable target for immunometabolism in non-small cell lung cancer using systems biology approach Research Paper

Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptations Review

Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Advancements in bladder cancer treatment: The synergy of radiation and immunotherapy Review

Computed tomography-based radiomics and body composition model for predicting hepatic decompensation Research Paper

HER2-low and HER2-zero in breast cancer between prognosis, prediction and entity Editorial

Bruton’s tyrosine kinase inhibitor-related cardiotoxicity: The quest for predictive biomarkers and improved risk stratification Research Perspective

GZ17-6.02 kills PDX isolates of uveal melanoma Research Paper

Combining causal and correlative approaches to discover biomarkers of response to paclitaxel Research Perspective

Peripheral surrogates of tumor burden to guide chemotherapeutic and immunotherapeutic strategies for HPV-associated malignancies Review

HER3- A key survival pathway and an emerging therapeutic target in metastatic colorectal cancer and pancreatic ductal adenocarcinoma Research Perspective

Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer Research Paper

Mutation analysis performed on tumor biopsies from patients with newly-diagnosed germinal center aggressive B cell lymphomas Research Paper

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study Research Paper

Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer Research Paper

Effectiveness of radiotherapy for local control in T3N0 rectal cancer managed with total mesorectal excision: a meta-analysis Research Paper

Genomic alterations predictive of poor clinical outcomes in pan-cancer Research Paper

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma Research Paper

Predicting cancer immunotherapy response from gut microbiomes using machine learning models Research Paper

Are anaplastic lymphoma kinase (ALK) and O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation driver biomarkers of pulmonary neuroendocrine tumors (NETs) and carcinomas (NECs)? Research Paper

Deciphering miR-520c-3p as a probable target for immunometabolism in non-small cell lung cancer using systems biology approach Research Paper

Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptations Review

Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers Research Paper